Figure 5.
Survival analysis was conducted to investigate the prognostic implications of 15 genes, including the five shared genes identified in all three gene lists and the ten hub genes
The analysis utilized the ULACAN online database and incorporated clinical data from breast cancer patients in the GSE76275 dataset. Both OS and RFS analyses were performed to assess the impact of gene expression on patient outcomes. Kaplan-Meier survival curves were generated using the ULACAN platform, providing a visual representation of the probability of survival over time for distinct gene expression groups. The statistical significance of survival differences between these groups was assessed using the log-rank test, with a P-value threshold of 0.05 considered statistically significant. Genes demonstrating a significant association with survival outcomes may be identified as potential prognostic markers.